Bristol Myers Squibb: A Quiet Yield

Bristol Myers Squibb is, undeniably, a large company. A giant, even, in a field populated by giants. The cost of conjuring something genuinely new from the laboratory is, of course, astronomical. They have, over the years, managed it, more often than not. But currently, they seem to exist somewhat apart from the prevailing enthusiasm. The market, naturally, prefers spectacle.

Sweetgreen’s Lament: A Salad’s Slow Decay

Comparable sales, those barometers of public appetite, retreated by 11.5% in the final quarter. Revenue, that lifeblood of any enterprise, dwindled to a mere $155.2 million. The company, it appears, miscalculated the public’s desire for expensive lettuce, missing estimates on all fronts. Their pronouncements for 2026 are less a forecast, more a weary sigh, predicting further decline and a compression of profit margins, as if squeezing water from a stone.

Kirby Corp: A CEO’s Calculus

The figures, stark and unyielding, tell a partial story. The weighted average purchase price of $130.05, a sum arrived at through the cold logic of the market, is but a single data point in a larger, more unsettling equation. To focus solely on the financial aspect is to miss the underlying drama—the CEO, a man entrusted with the stewardship of a substantial enterprise, making a calculated move, a preemptive strike against the uncertainties that haunt all who dare to participate in this relentless game.

G2’s Semiconductor Shuffle

Tower Semiconductor Image

G2, you see, had been rather fond of Tower Semiconductor, owning a good 4.2% of the company. But they trimmed that down to a measly 2.07%. It’s like a greedy giant deciding he’s had enough cake. They’ve probably got other sugary treats in their pockets, mind you. The value of their remaining holdings shrunk by $12.27 million, which is a bit like losing a pocketful of marbles – annoying, but not catastrophic.

Bitcoins and Blithering Fools

There’s a fellow, a Mr. Geoff Kendrick – a rather important person at a bank called Standard Chartered (a name that sounds suspiciously like a villain from a penny dreadful) – who thinks things might get a little worse before they get…well, possibly better. He’s warning people not to get too attached to their digital treasures, because folks are still emptying these ‘ETFs’ – which sound like a particularly nasty sort of insect infestation – at a rather alarming rate. Apparently, these ETF holdings have shrunk by around 25%, which is a bit like watching your sweets slowly disappear.

Digital Echoes: A Cautious Bloom

The so-called cryptocurrencies, those phantom currencies born of the late twentieth and early twenty-first centuries, have endured a particularly harsh season. Unlike the solid weight of gold, or the tangible promise of a well-tended field, these currencies exist as whispers in the network, vulnerable to the whims of sentiment and the unpredictable dance of supply and demand. They are not tied to the rhythm of harvests, or the honest labor of hands, but to the fleeting passions of a digital populace. And yet, as Mateo well knew, even phantoms can cast long shadows, and even whispers can swell into a roar.

Buffett’s Exit: A Full Hand and an Empty Table

For decades, the Oracle of Omaha built an empire. A conglomerate that dwarfed most nations. Returns that made the S&P 500 look like a penny stock. The Dow? A slow waltz. Nasdaq? A jitterbug with a broken leg. But the game changed when he started folding, not raising.

Quantum Leaps & My Portfolio’s Existential Dread

The idea is that if you find a small company in a burgeoning field, one with the potential to become absolutely enormous, you could see returns that defy logic. IonQ, at a market cap of around twelve billion dollars, would need to multiply by a factor of one hundred to reach the trillion-dollar club. Nine companies already occupy that space, which, statistically, isn’t impossible. But then, so wasn’t my cousin Barry becoming a competitive hot dog eater, and look how that turned out. He’s mostly just heartburn now.

Nike: A Pause in the Decline

The difficulties at Nike were not merely cosmetic, a fleeting fashion faux pas. They were structural, a consequence of believing its own publicity. The fiscal year 2025 saw a decline of approximately ten per cent in revenue – a rare indignity for a company accustomed to the steady accumulation of wealth. Gross margins, predictably, suffered – a shrinkage of 190 basis points to a rather dismal 42.7 per cent – as the desperate need to offload surplus stock necessitated increasingly generous discounts. The brand, of course, retained a certain allure, but the underlying mechanism, the efficient delivery of goods, had become alarmingly rickety.